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Introduction 
 
Memory is a fundamental cognitive ability that enables 
humans to learn and remember information, providing 
meaning and context to daily events. Episodic memory, 
which refers to the encoding and retrieval of facts that occur 
at a specific time, is thought to have a heritability of 
approximately 50 percent (McClearn et al., 1997). A whole-
genome association study in 2006 identified an association 
between a single nucleotide polymorphism (SNP) in the 
KIBRA gene and episodic memory (Passotiropoulos et al., 
2006).  This one genetic aspect of memory provided a 
promising target for memory-enhancing pharmaceuticals. 
Huentelman et al. (2009) used hydroxyfasudil to inhibit the 
RhoA/ROCK/Rac pathway in a mouse model. This pathway 
had been previously reported to be upstream of PKC-ζ, one 
of KIBRA’s binding partners. Using this pharmaceutical, 
Huentelman et al. (2009) observed spatial learning and 
working memory improvement in aged rats, suggesting a 
possible therapy to treat cognitive impairment such as that 
seen in Alzheimer’s disease, cushion the impact of aging on 
memory, or simply enhance learning and memory. However, 
the associations between KIBRA, memory, and this drug 
have not yet been elucidated.  
 Very little detail is known about the pathways to 
which this gene contributes; however, research implicates 
that the cytoplasmic protein plays a structural role in neurons 
(Kremerskothen et al., 2003). Multiple studies examining the 
gene’s association with memory performance found 
consistent and age-independent results in healthy individuals 
(Passotiropoulos et al., 2006; Schaper, Kolsch, Popp, 
Wagner, and Jesseen, 2008); however, conflicting results 
when examining subjects with impaired memory suggest 
KIBRA’s effects are complex and may even be involved in 
Alzheimer’s disease (Rodriguez-Rodriguez et al., 2009; 
Corneveaux et al., 2008). The precise mechanisms through 
which KIBRA contributes to these pathways will only be 
understood through further research. Therefore, a 
conditional knockout of KIBRA in a mouse model should be 
created to better understand the role KIBRA plays in 
memory. This pathway, once elucidated, will confirm 
KIBRA’s association to memory and the drug hydroxyfasudil, 
as well as allow for the discovery and understanding of 
therapies that can potentially treat either non-disabling 
memory declines associated with healthy aging and impaired 
memory associated with diseases such as Alzheimer’s. 
 
Specific Aims 
 
1. The first goal is to produce a conditional knockout mouse 
of the KIBRA gene using the Cre/loxP system and the 
αCaMKII promoter. A mouse line will first be created in 
which the KIBRA gene is floxed, allowing for the deletion of 
the gene upon crossing with a mouse containing the Cre 
recombinase protein and αCaMKII promoter (Tsien et al., 
1996). It is hypothesized that the deletion of the KIBRA gene 
will be restricted to the forebrain, the memory center of the 
brain, and will result in decreased memory.  
________________________________________________  
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2. The second goal of this proposal is to examine the spatial 
learning and working memory of these mouse models in 
comparison to a control group to determine if memory has 
deteriorated as hypothesized. 
 
Experimental Procedure 
 
Previous work had showed that a SNP in the KIBRA gene is 
associated with memory. However, the pathway through 
which this association occurs is not understood. In order to 
verify the relationship between the KIBRA gene and episodic 
memory, a conditional knockout mouse will be produced to 
determine if deteriorated episodic memory ensues. A 
promoter specific to the hippocampus of the forebrain, 
αCaMKII, will be used. KIBRA has been found to be highly 
expressed in the liver and kidney, while intermediate 
expression was detected in the brain, lung, pancreas, and 
ovary (Nagase et al, 1998). This tissue-specific promoter 
will, therefore, ensure that KIBRA activity in other tissue 
areas is not affected; furthermore, KIBRA will only be 
deleted in the hippocampus and not other regions of the 
brain, such as the hypothalumus, which are not involved in 
memory. The αCaMKII promoter has been shown to initiate 
Cre/loxP recombination during the middle of the third 
postnatal week in murine models (Tsien et al., 1996); this 
characteristic is critical, for KIBRA is thought to be involved 
in brain development and memory formation. The promoter 
will prevent inhibition of prenatal neural development and will 
delete the KIBRA gene only in the memory-related brain 
region of the hippocampus. 
The sequence flanking the KIBRA gene will first be 
obtained from the NCBI website. A modified targeting vector 
containing two loxP sites, the neomycin resistance gene 
(neo), as well as the thymidine kinase (tk) gene, will be 
obtained. Via pronuclear injection of an embryonic mouse 
stem cell (ES cell), this vector will be used to flank the 
KIBRA gene with loxP, as well as insert the neomycin 
resistant gene (Dragatsis & Zeitlin, 2000; Erdmann et al., 
2007). G418 will be used to ensure the neomycin gene is 
transferred while ganciclovir will be added to cells with G418 
resistance to ensure homologous recombination; non-
homologous integration will result in cell death due to the 
remaining tk gene.  Surviving ES cells will be injected into 
the inner cell mass of a fresh blastocyst and implanted into a 
pseudo-pregnant female (Dragatsis & Zeitlin, 2000; Erdmann 
et al., 2007). Chimeric offspring will be crossed with wild-
type mice to generate heterozygotes, which will be bred to 
obtain floxed KIBRA homozygotes. 
 Mice containing the αCaMKII-Cre transgene will 
be obtained from Riken Bioresource Center: Experimental 
Animal Division (http://www2.brc.riken.jp/lab/animal/ 
detail.php?brc_no=RBRC00254). Crossing these mice with 
mice homozygous for the floxed KIBRA gene will produce 
offspring in which the KIBRA gene will be deleted upon 
activation of the αCaMKII promoter. This activation will 
naturally occur during the middle of the third postnatal week, 
ensuring the completion of neurological development (Tsien 
et al., 1996).  
 To determine if deteriorated memory ensues, 
these mice will undergo a series of spatial learning and 
working memory tests, including radial-arm mazes and water 
maze test as described by Huentelman et al. (2009). Scores 
will be examined as the mice age to determine if a memory 
decline is observed as KIBRA inactivation develops. In situ 
hybridization and immunochemistry of brain sections will be 
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performed as detailed by Johannsen et al. (2008) to examine 
KIBRA levels in various tissue sections every three weeks. 
Levels of the KIBRA protein and memory scores of 
transgenic mice will be compared to wild-type mice.  
 Due to the KIBRA deletion, it is expected that 
transgenic mice will exhibit deteriorated spatial learning and 
working memory. This result would confirm KIBRA’s role in 
memory, as well as the relationship KIBRA has to the 
aforementioned drug hydroxyfasudil, a pharmaceutical used 
in wild-type mice to improve memory. Furthermore, these 
transgenic mice will be used as a model to identify other 
pharmaceuticals that improve memory impairment related to 
the KIBRA gene.  
 It is expected that KIBRA will be deleted in only 
the forebrain and that no deletions will occur until three 
weeks after birth. However, if development does not proceed 
normally or a lethal phenotype ensues, the tetracycline 
system (Tet-off) will be examined as a possible substitute to 
the conditional knockout described in this report. This 
alternative experiment, however, is beyond the scope of this 
proposal.  
 
Conclusion 
 
These experiments will determine if the deletion of the 
KIBRA gene in the forebrain, the memory center of the brain, 
results in impaired memory. This information will not only 
confirm KIBRA’s association with memory, but will provide a 
murine model to elucidate the mechanism behind this 
relationship. Furthermore, this model could be used to 
identify other pharmaceuticals that improve memory  
impairment related to the KIBRA gene.  
 
Note: Eukaryon is published by students at Lake Forest 
College, who are solely responsible for its content. The 
views expressed in Eukaryon do not necessarily reflect 
those of the College. Articles published within Eukaryon 
should not be cited in bibliographies. Material contained 
herein should be treated as personal communication and 
should be cited as such only with the consent of the author. 
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